Aspire Private Capital, LLC Amgen Inc Transaction History

Aspire Private Capital, LLC

$416 Million
Q3 2024

A detailed history of Aspire Private Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Aspire Private Capital, LLC holds 300 shares of AMGN stock, worth $88,358. This represents 0.02% of its overall portfolio holdings.

Number of Shares

300

Previous 318 5.66%

Holding current value

$88,358

Previous $99,000 3.03%

% of portfolio

0.02%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$309.38 - $337.38 $5,568 - $6,072	-18 Reduced 5.66%	300 $96,000
Q2 2024 Jul 15, 2024	BUY	$262.75 - $319.31 $3,153 - $3,831	12 Added 3.92%	318 $99,000
Q1 2024 Apr 18, 2024	SELL	$268.87 - $324.56 $537 - $649	-2 Reduced 0.65%	306 $87,000
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $9,460 - $10,673	-37 Reduced 10.72%	308 $88,000
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $1,967 - $2,443	9 Added 2.68%	345 $92,000
Q2 2023 Jul 24, 2023	BUY	$214.27 - $253.37 $8,356 - $9,881	39 Added 13.13%	336 $74,000
Q1 2023 May 30, 2023	BUY	$225.79 - $275.2 $4,967 - $6,054	22 Added 8.0%	297 $71,000
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $4,967 - $6,054	22 Added 8.0%	297 $71,000
Q4 2022 May 30, 2023	SELL	$229.03 - $291.01 $5,038 - $6,402	-22 Reduced 7.41%	275 $72,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $458 - $582	-2 Reduced 0.72%	275 $72,000
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $448 - $506	-2 Reduced 0.72%	277 $62,000
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $230 - $256	1 Added 0.36%	279 $68,000
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $6,797 - $7,519	-31 Reduced 10.03%	278 $67,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $596 - $682	-3 Reduced 0.96%	309 $70,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $4,033 - $4,725	-19 Reduced 5.74%	312 $66,000
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $60,497 - $67,117	-259 Reduced 43.9%	331 $81,000
Q1 2021 May 26, 2021	SELL	$221.91 - $258.6 $168,429 - $196,277	-759 Reduced 56.26%	590 $147,000
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $1,514 - $1,803	-7 Reduced 0.52%	1,349 $310,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $33,085 - $36,793	141 Added 11.6%	1,356 $345,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $36,792 - $45,149	186 Added 18.08%	1,215 $287,000
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $75,994 - $100,788	-417 Reduced 28.84%	1,029 $209,000
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $144,745 - $186,048	765 Added 112.33%	1,446 $349,000
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $8,705 - $10,431	50 Added 7.92%	681 $132,000
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $12,835 - $15,046	77 Added 13.9%	631 $116,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $17,544 - $19,776	-97 Reduced 14.9%	554 $105,000
Q4 2018 Feb 25, 2019	BUY	$178.4 - $208.25 $104,542 - $122,034	586 Added 901.54%	651 $127,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $11,596 - $13,536	65 New	65 $127,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.

Account

Aspire Private Capital, LLC Amgen Inc Transaction History